BDX-XL2

The BDX-XL2 test is covered only for management of solitary lung nodules 8–30 mm in diameter in patients aged 40 years or older whose pre-test cancer risk is 50% or less as calculated by the Mayo Clinic Model. The test is intended to identify nodules likely to be benign so that patients may be managed with non-invasive CT surveillance instead of invasive procedures; testing outside these specified criteria is not covered.

"BDX-XL2 is covered for management of a solitary lung nodule with diameter between 8 mm and 30 mm."

Sign up to see full coverage criteria, indications, and limitations.